Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP binding cassette subfamily C member 6 pseudogene 1 (ABCC6P1) is a **transcriptionally active pseudogene** related to the ABCC6 gene, which encodes an ATP-dependent transporter implicated in molecular export and human disease, notably pseudoxanthoma elasticum[1][3]. Unlike ABCC6, ABCC6P1 does **not encode a functional protein** but it is co-expressed with ABCC6 in several tissues—particularly liver and kidney—and can influence the mRNA levels of the parental ABCC6 gene, as demonstrated by siRNA knockdown studies indicating regulatory interdependence[1]. ABCC6P1 is not a therapeutic target (such as a receptor, enzyme, or transporter) and is best considered a *regulatory non-coding RNA* rather than a classic protein-coding drug target[1][3]. No drugs or direct biomarker roles are documented for ABCC6P1; its main biological significance lies in modulating the expression of the adjacent ABCC6 gene via its transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP binding cassette subfamily C member 6 pseudogene 1 (ABCC6P1).